BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31132340)

  • 1. Progestogens for the prevention of preterm birth and risk of developing gestational diabetes mellitus: a meta-analysis.
    Pergialiotis V; Bellos I; Hatziagelaki E; Antsaklis A; Loutradis D; Daskalakis G
    Am J Obstet Gynecol; 2019 Nov; 221(5):429-436.e5. PubMed ID: 31132340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis.
    Boelig RC; Locci M; Saccone G; Gragnano E; Berghella V
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100658. PubMed ID: 35562009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogens in singleton gestations with preterm prelabor rupture of membranes: a systematic review and metaanalysis of randomized controlled trials.
    Quist-Nelson J; Parker P; Mokhtari N; Di Sarno R; Saccone G; Berghella V
    Am J Obstet Gynecol; 2018 Oct; 219(4):346-355.e2. PubMed ID: 29614278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.
    Nelson DB; McIntire DD; McDonald J; Gard J; Turrichi P; Leveno KJ
    Am J Obstet Gynecol; 2017 Jun; 216(6):600.e1-600.e9. PubMed ID: 28223163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.
    EPPPIC Group
    Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery.
    Oler E; Eke AC; Hesson A
    Int J Gynaecol Obstet; 2017 Jul; 138(1):12-16. PubMed ID: 28369874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
    Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V
    Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17α-Hydroxyprogesterone Caproate and the Risk of Glucose Intolerance in Pregnancy: A Systematic Review and Meta-analysis.
    Eke AC; Sheffield J; Graham EM
    Obstet Gynecol; 2019 Mar; 133(3):468-475. PubMed ID: 30741815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone and preterm birth.
    Norman JE
    Int J Gynaecol Obstet; 2020 Jul; 150(1):24-30. PubMed ID: 32524598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal administration of progesterone for preventing preterm birth.
    Dodd JM; Flenady V; Cincotta R; Crowther CA
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004947. PubMed ID: 16437505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2022 Sep; 227(3):440-461.e2. PubMed ID: 35460628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.
    Rebarber A; Istwan NB; Russo-Stieglitz K; Cleary-Goldman J; Rhea DJ; Stanziano GJ; Saltzman DH
    Diabetes Care; 2007 Sep; 30(9):2277-80. PubMed ID: 17563346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth.
    Nelson DB; McIntire DD; Leveno KJ
    Am J Obstet Gynecol; 2021 Feb; 224(2):175-186. PubMed ID: 33035472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials.
    Suhag A; Saccone G; Berghella V
    Am J Obstet Gynecol; 2015 Oct; 213(4):479-87. PubMed ID: 25797233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal progesterone is associated with decreased group B streptococcus colonisation at term: a retrospective cohort study.
    Ma'ayeh M; Rood KM; Walker HC; Oliver EA; Gee SE; Iams JD
    BJOG; 2019 Aug; 126(9):1141-1147. PubMed ID: 31094064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant 17-hydroxyprogesterone caproate in women with history-indicated cerclage: A systematic review and meta-analysis.
    Eke AC; Sheffield J; Graham EM
    Acta Obstet Gynecol Scand; 2019 Feb; 98(2):139-153. PubMed ID: 30339274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.